Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02364960 · ClinicalTrials.gov registry record
Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)
A clinical trial, sponsored by TriHealth.
- Terminated
- Registry status
- 16
- Enrollment target
NCT02364960: Clinical Trial study, sponsored by TriHealth.
NCT02364960 is a clinical trial that was terminated before completion, run by TriHealth. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02364960 was terminated before completion, sponsored by TriHealth.
- TERMINATED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to create a registry to evaluate the use of intra-operative radiation therapy (IORT) and to study the efficacy and toxicity of breast radiotherapy given intra-operatively as a single fraction after breast conserving surgery,
Primary Outcome
In-breast local failure is defined as recurrence of cancer in the ipsilateral (same side) breast. Following IORT, patients will be monitored every 6 months for 3 years, and then annually in years 4 and 5 to determine if cancer has returned. In years 6 through 10 medical records will be reviewed to obtain information on participants' breast cancer status.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-01 |
Why NCT02364960 stopped before completion
NCT02364960 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02364960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02364960 about?
NCT02364960 is a clinical study titled "Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)". The purpose of this study is to create a registry to evaluate the use of intra-operative radiation therapy (IORT) and to study the efficacy and toxicity of breast radiotherapy given intra-operatively as a single fraction after breast conserving surgery,
What is the current status of trial NCT02364960?
This trial is currently terminated. The enrollment target is 16 participants. The study started on 2015-01. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT02364960?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia